Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Additional clinical data not required for approval of Seasonique

March 21, 2006

New agents for treating thrombocythemia reported in recent Shire patent

March 20, 2006

FDA approval for Yaz

March 17, 2006

Novel treatment options for metabolic disorders described in recent patents

March 17, 2006

Recent patents describe new treatments for endocrine-related disorders

March 17, 2006

Chrysalin fails to meet primary efficacy endpoint in fracture repair study

March 17, 2006

Phenoptin reduces blood phenylalanine levels in PKU study

March 17, 2006

Xechem seeks orphan drug designation for antisickling agent 5-HMF

March 17, 2006

Novel ACAT inhibitor SMP-797 enhances hepatic LDL receptor expression

March 17, 2006

CamBP collaborates with BTG

March 17, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...